People with celiac disease have long reported that the condition is far more than a dietary inconvenience. Fatigue, persistent symptoms, and ongoing health struggles follow many patients even after diagnosis—and even on a strict gluten-free diet. New research published in Gastro Hep Advances is measuring that hidden burden with a concrete tool: registered sick leave.
The study tracked thousands of celiac patients across Denmark, comparing their absence records—before and after their diagnosis—to a large matched group of people without celiac disease. For those of us raising children with celiac, research like this matters. My son is ten years old. The gluten-free diet is manageable today, but the disease will follow him into adulthood. How it affects his working life is not an abstract concern.
What This Means for You
Missed workdays are an objective measure of how much a disease disrupts daily functioning. Unlike self-reported symptoms—which vary in how people describe them and can be hard to compare across studies—employment records reflect what actually happened: someone filed for sick leave, or they did not.
The Danish research team drew on the National Patient Register to identify all patients diagnosed with celiac disease between 2008 and 2017, limiting the cohort to working-age adults between 25 and 60 at the time of diagnosis. They then matched each patient with ten people of the same age and sex who did not have celiac disease. By examining sick leave data spanning both before and after the celiac diagnosis, the study traces the full arc of disease burden—not just a single moment.
This design captures something celiac patients know well: the pre-diagnosis years. Celiac disease is notoriously hard to identify. Symptoms are vague, overlap with other conditions, and often persist for years before anyone connects them to gluten. During that window, patients may be struggling—fatiguing faster, missing work, underperforming—without understanding why. Sick leave records can reveal that struggle even when patients themselves haven’t yet named it.
The study also examined disability pension rates—a permanent benefit for workers whose health prevents them from maintaining employment. Including this measure captures the most severe end of the spectrum: patients for whom the disease’s cumulative impact ended careers entirely.
This research builds on a pattern the celiac community has been raising for years. We covered related ground in Celiac Disease Tied to Fatigue, Poor Health, and Care Gaps, which documented how patients report ongoing symptoms and fragmented care even after diagnosis. Sick leave data gives researchers a way to quantify that experience in economic terms—one that is harder to dismiss than self-report alone.
Key Takeaways
- Researchers tracked sick leave in celiac patients before and after diagnosis using Denmark’s national employment registry.
- Each celiac patient was matched with ten controls of the same age and sex who did not have celiac disease.
- The study covers patients diagnosed between 2008 and 2017—a decade-long nationwide cohort of working-age adults.
- Sick leave before diagnosis may reveal the economic cost of the pre-diagnosis years, when patients are symptomatic but unidentified.
- The study also captures disability pension rates, reflecting cases where the disease burden became severe enough to prevent continued employment.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
Why Sick Leave Instead of Symptoms?
Patient-reported symptoms are valuable, but they have real limitations. People describe pain and fatigue differently. Thresholds vary across individuals and cultures. Symptom data is usually collected in clinical settings that don’t reflect daily life at home or at work.
Register-based data—drawn from national administrative records like employment files or patient registries—sidesteps these problems. It reflects observable behavior: someone filed for sick leave, or they continued working. Denmark is especially well-suited for this kind of study. Its national registries link healthcare records, employment data, and social benefits at the individual level, with near-universal participation. Researchers can follow entire populations over time without the dropout rates or selection bias that limit smaller studies.
The Cohort Design
The study uses a longitudinal cohort design—following the same group of people over time rather than taking a single snapshot. All patients diagnosed with celiac disease through the National Patient Register between 2008 and 2017, aged 25 to 60 at diagnosis, were included. That age range captures working-age adults: the population most likely to have employment records worth examining.
To create a valid comparison, the team applied 1:10 matching: for every celiac patient, ten individuals of the same age and sex without a celiac diagnosis were selected from the same registry. This large comparison group gives the study statistical power to detect meaningful differences even in subgroup analyses—for example, comparing patterns in men versus women, or in patients diagnosed earlier versus later in the study period.
The Pre-Diagnosis Window
One of the most analytically important features of this study is the data collected before diagnosis. Most celiac patients experience a diagnostic delay—the gap between when symptoms begin and when a diagnosis is confirmed. In Western countries, that delay is estimated at several years on average.
During this window, the intestinal lining is already sustaining mucosal damage (injury to the small intestine’s inner surface) from ongoing gluten exposure. Symptoms like fatigue, abdominal pain, and neurological complaints may already be affecting daily functioning—including the ability to work—without any clinical explanation yet on file. If sick leave rates are already elevated in the pre-diagnosis period among patients who later receive a celiac diagnosis, that finding would have significant implications: it suggests earlier diagnosis could deliver economic benefits, not just medical ones.
After Diagnosis: Does the Gluten-Free Diet Restore Work Capacity?
Starting a strict gluten-free diet should reduce the immune response that drives celiac symptoms. Over time, intestinal healing typically follows. In theory, sick leave rates should decrease after diagnosis and dietary treatment begin.
Whether that actually happens—and how quickly—is exactly what this study was built to examine. It’s possible that sick leave rates normalize to match the general population after diagnosis. It’s also possible they remain elevated, reflecting the ongoing demands of managing a strict diet in workplaces not designed to accommodate it, or the persistence of extraintestinal manifestations (symptoms outside the digestive system, such as joint pain, anemia, or neurological symptoms) that may not fully resolve on a gluten-free diet alone.
Disability Pension as the Severity Marker
The inclusion of disability pension data adds an important dimension. This benefit is granted to workers whose health prevents them from sustaining employment—it is not a short-term sick leave but a permanent employment exit. If celiac patients are over-represented in disability pension records compared to matched controls, it indicates that for some patients, the disease’s cumulative burden becomes insurmountable.
Immunogenic peptides—protein fragments derived from gluten that trigger the immune cascade in celiac patients—drive intestinal inflammation. But their effects extend well beyond the gut. Gluten ataxia (a neurological condition affecting coordination and balance linked to gluten exposure in susceptible individuals) and other systemic complications can affect sustained work capacity in ways that outlast dietary changes.
Why This Study Matters Beyond Denmark
This is Danish data, and Denmark’s welfare system and employment structure differ from those in the United States and many other countries. But the underlying biology is the same everywhere celiac disease occurs, and so is the core question: does celiac disease affect working life in measurable ways?
Register-based research from Scandinavian countries—where population registries are comprehensive and long-established—often serves as high-quality evidence for phenomena that are harder to study elsewhere. What this study documents in Denmark likely reflects patterns present in celiac populations globally, even if the specific sick leave rates would differ by country.
For the celiac community, this kind of evidence builds the foundation for broader recognition of the disease’s real-world impact. When researchers can show that celiac disease is associated with elevated sick leave and disability pension rates in a nationwide cohort, it becomes harder to dismiss the condition as a manageable dietary issue with minimal broader consequences. That matters for policy, for workplace accommodations, and for the patients and families who have been making this case for years—often without data to back them up.
I want my son to grow up into a world that takes his condition seriously—not just at the dinner table, but in every space he inhabits. Studies like this one are a step in that direction.
Related Coverage
References
Schovsbo SU, Bjerregaard AA, Riis MS, et al. Registered Sick Leave in Celiac Disease: A Register-Based Nationwide Cohort Study. Gastro Hep Advances. 2026;5(8):100989. doi:10.1016/j.gastha.2026.100989. PubMed